MRK’s hit from ObamaCare is relatively low because MRK does not compete in the antipsychotic market. Antipsychotics have the biggest Medicaid tab of any drug class, and hence they are the most exposed to the higher Medicaid rebates under ObamaCare.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.